Subscribe to our Private Equity & Business Newsletter

Healthcare & Pharmaceuticals

  • Hims & Hers Jumps 23% on Novo Nordisk Deal.  Hims & Hers signed a deal for distribution with Novo Nordisk. Novo Nordisk has fallen behind Eli Lilly and Company.
  • “The Danish drugmaker is expanding Wegovy access via telehealth providers like Hims and Ro. But the gap with Eli Lilly is only getting wider.” The Wall Street Journal.

Leave a Reply

Your email address will not be published. Required fields are marked *

More News